284686-17-5

Basic information

• Product Name: N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine
• Synonyms: N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine
• CAS NO: 284686-17-5
• Molecular Formula: C9H11N3O2
• Molecular Weight: 193
• Product Categories: Metabolites & Impurities;Pharmaceuticals;Aromatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals;Aromatics;Intermediates & Fine Chemicals
• Mol File: 284686-17-5.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Solubility: Dichloromethane
• CAS DataBase Reference: N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine(284686-17-5)
• EPA Substance Registry System: N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine(284686-17-5)

Safety Data

• Hazardous Substances Data: 284686-17-5(Hazardous Substances Data)

Usage

Chemical Properties

Brown Oil

Uses

Intermediate in the preparation of Nevirapine metabolites.

Upstream product

• 23056-39-5 2-chloro-3-nitro-4-methylpyridine 
• 765-30-0 Cyclopropylamine 

Downstream Products

• 284686-32-4 2-chloro-N-[(2'-cyclopropylamino)-4'-methyl-3'-pyridyl]-8-nitro-3-pyridinecarboxamide 
• 284686-20-0 2-chloro-N-[5'-bromo-4'-methyl-2'-cyclopropylamino-3'-pyridinyl]-3-pyridinecarboxamide 
• 284686-34-6 8-amino-11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 
• 284686-22-2 11-cyclopropyl-5,11-dihydro-4-methyl-3-vinyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 
• 284686-21-1 3-bromo-11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 
• 284686-19-7 2-chloro-N-[(2'-cyclopropylamino)-4'-methyl-3'-pyridyl]-3-pyridinecarboxamide 
• 174532-77-5 11-cyclopropyl-5,11-dihydro-3-formyl-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 
• 284686-18-6 3-amino-2-cyclopropylamino-4-methylpyridine 

Relevant articles and documents

Dipyridodiazepinone derivatives; synthesis and anti HIV-1 activity

Ten dipyridodiazepinone derivatives were synthesized and evaluated for their anti HIV-1 reverse transcriptase activity against wildtype and mutant type enzymes, K103N and Y181C. Two of them were found to be promising inhibitors for HIV-1 RT.